1. Home
  2. DNLI vs NSP Comparison

DNLI vs NSP Comparison

Compare DNLI & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • NSP
  • Stock Information
  • Founded
  • DNLI 2013
  • NSP 1986
  • Country
  • DNLI United States
  • NSP United States
  • Employees
  • DNLI N/A
  • NSP N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • NSP Professional Services
  • Sector
  • DNLI Health Care
  • NSP Consumer Discretionary
  • Exchange
  • DNLI Nasdaq
  • NSP Nasdaq
  • Market Cap
  • DNLI 2.1B
  • NSP 2.4B
  • IPO Year
  • DNLI 2017
  • NSP 1997
  • Fundamental
  • Price
  • DNLI $13.92
  • NSP $59.74
  • Analyst Decision
  • DNLI Strong Buy
  • NSP Hold
  • Analyst Count
  • DNLI 15
  • NSP 3
  • Target Price
  • DNLI $33.85
  • NSP $80.00
  • AVG Volume (30 Days)
  • DNLI 1.5M
  • NSP 403.7K
  • Earning Date
  • DNLI 08-04-2025
  • NSP 08-01-2025
  • Dividend Yield
  • DNLI N/A
  • NSP 4.04%
  • EPS Growth
  • DNLI N/A
  • NSP N/A
  • EPS
  • DNLI N/A
  • NSP 1.65
  • Revenue
  • DNLI N/A
  • NSP $6,642,000,000.00
  • Revenue This Year
  • DNLI N/A
  • NSP $4.83
  • Revenue Next Year
  • DNLI $323.34
  • NSP $5.99
  • P/E Ratio
  • DNLI N/A
  • NSP $36.09
  • Revenue Growth
  • DNLI N/A
  • NSP 1.90
  • 52 Week Low
  • DNLI $10.57
  • NSP $56.36
  • 52 Week High
  • DNLI $33.33
  • NSP $104.90
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 45.66
  • NSP 48.53
  • Support Level
  • DNLI $13.70
  • NSP $56.36
  • Resistance Level
  • DNLI $14.60
  • NSP $60.29
  • Average True Range (ATR)
  • DNLI 0.65
  • NSP 1.47
  • MACD
  • DNLI -0.06
  • NSP 0.36
  • Stochastic Oscillator
  • DNLI 13.13
  • NSP 56.52

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

Share on Social Networks: